Feasibility of targeted alpha therapy for Alzheimer's disease using 211At-labeled agent targeting amyloid-β aggregates
{{output}}
Objective: Amyloid-β (Aβ) aggregates have been recognized as therapeutic targets for Alzheimer's disease (AD). Targeted alpha therapy (TAT) using α-particles has the potential to be applied as a novel treatment approach for A... ...
